Early myoclonic encephalopathy
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes.
|
27604308 |
2016 |
Early myoclonic encephalopathy
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
SLC25A22 is a novel gene for migrating partial seizures in infancy.
|
24596948 |
2013 |
Early myoclonic encephalopathy
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy.
|
15592994 |
2005 |
Early myoclonic encephalopathy
|
0.700 |
GeneticVariation
|
disease |
CLINVAR |
Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy.
|
15592994 |
2005 |
Early myoclonic encephalopathy
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Impaired mitochondrial glutamate transport in autosomal recessive neonatal myoclonic epilepsy.
|
15592994 |
2005 |
Early myoclonic encephalopathy
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Early myoclonic encephalopathy
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Early myoclonic encephalopathy
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Early infantile epileptic encephalopathy with suppression bursts
|
0.300 |
GermlineCausalMutation
|
disease |
ORPHANET |
Mutations in the mitochondrial glutamate carrier SLC25A22 in neonatal epileptic encephalopathy with suppression bursts.
|
19780765 |
2009 |
Epileptic encephalopathy
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SLC25A22 are known to cause neonatal epileptic encephalopathy and migrating partial seizures in infancy.
|
28255779 |
2017 |
Epileptic encephalopathy
|
0.120 |
GeneticVariation
|
disease |
BEFREE |
Comparison of the clinical features of patients from both families suggests that SLC25A22 mutations are responsible for a novel clinically recognizable epileptic encephalopathy with SB.
|
19780765 |
2009 |
Epileptic encephalopathy
|
0.120 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Mutations in SLC25A22: hyperprolinaemia, vacuolated fibroblasts and presentation with developmental delay.
|
28255779 |
2017 |
X-linked infantile spasms
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Specific mutations in at least four genes (whose protein products are essential in lower brain's neuronal and interneuronal functions, including mitochondrial respiratory chains have been identified in unrelated individuals with EIEE and include: (a) the ARX (aristaless-related) homeobox gene at Xp22.13 (EIEE-1 variant); (b) the CDKL5 (SYK9) gene at Xp22 (EIEE-2 variant); (c) the SLC25A22 (GC1) gene at 11p15.5 (EIEE-3 variant); and (d) the Stxbp1 (MUNC18-1) gene at 9q34-1 (EIEE-4 variant).
|
21967765 |
2012 |
Global developmental delay
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Global developmental delay
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
X-linked infantile spasms
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Tonometry
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analyses identify new loci influencing intraocular pressure.
|
29617998 |
2018 |
Cleft Palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Febrile Convulsions
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Deglutition Disorders
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Dyskinetic syndrome
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Dystonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Failure to Thrive
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Ventricular Septal Defects
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|